School of Medicine

Showing 271-280 of 13,055 Results

• Tierra Aubrianna Allen

  Standardized Patient, Standardized Patient Program
  
• William Allen

  Assistant Professor of Developmental Biology
  
• 

  Marcus Alley

  Senior Research Scientist - Physical, Rad/Radiological Sciences Laboratory
  
• 

  Debra Allison

  Administrative Manager to Catalyst Executive Director & Catalyst Program Adm, Catalyst
  
• 

  Kimberly Allison

  Professor of Pathology
  

  Current Research and Scholarly InterestsDr. Allison’s clinical expertise is in breast pathology. Her research interests include how standards should be applied to breast cancer diagnostics (such as ER and HER2 testing), the utility of molecular panel-based testing in breast cancer, digital pathology applications and identifying the most appropriate management of specific pathologic diagnoses.
• 

  Johanna Maria Alm

  Fellowship Program Lead, Med/Residency and Educational Programs
  
• Lorraine Aceron Almeda

  Clinical Rsch Coord 2, Ophthalmology Research/Clinical Trials
  
• Laura Rodrigues Almeida

  Life Science Research Professional 1, Stem Cell Bio Regenerative Med Institute
  
• Patrick Almhjell

  Postdoctoral Scholar, Biochemistry
  

  • Contact Info

    almhjell@stanford.edu
• 

  Christopher Almond

  Professor of Pediatrics (Cardiology)
  

  BioChristopher Almond, MD, MPH is Professor of Pediatrics in the Division of Cardiology at the Stanford University School of Medicine where he is a board-certified pediatric cardiologist at Stanford's Lucile Packard Children's Hospital in Palo Alto, CA. His clinical and research interests are focused on pediatric heart failure, mechanical circulatory support, heart transplantation, and anticoagulation. He completed his training in pediatrics, cardiology, and a senior fellowship in heart failure/transplant at Boston Children's Hospital before before appointment as Assistant Professor of Pediatrics at Harvard Medical School/Boston Children’s Hospital. Dr. Almond completed his MPH at the Harvard School of Public Health with a focus on statistics and epidemiology (study design for rare diseases) followed by a Medical Device Fellowship at the FDA in the Division of Cardiovascular Devices at CDRH. Dr. Almond moved to Stanford in 2014 where he currently serves as professor of pediatrics and directs the clinical research program within Pediatric Advanced Cardiac Therapies (PACT) Program. He also serves as Medical Director of the Children’s Heart Center Anticoagulation Management Program at Stanford (CHAMPS). Dr. Almond has a passion for collaborative research serving as PI for federally-funded multi-center clinical trials including the Berlin Heart ventricular assist device (VAD) FDA Trial that led to its FDA approval in 2011, the TEAMMATE (everolimus for heart transplant) Trial, the TROLLEY (Cardiohelp ECMO/anticoagulation RCT in heart failure) Trial, the NHLBI PumpKIN (Jarvik 2015 LVAD) Trial, and the SPOT BIAS Trial, an FDA-funded trial to understand racial/pigment bias in commercial pulse oximeters.